One reporter for in-cell activity profiling of majority of protein kinase oncogenes
Iva Gudernova,
Silvie Foldynova-Trantirkova,
Barbora El Ghannamova,
Bohumil Fafilek,
Miroslav Varecha,
Lukas Balek,
Eva Hruba,
Lucie Jonatova,
Iva Jelinkova,
Michaela Kunova Bosakova,
Lukas Trantirek,
Jiri Mayer,
Pavel Krejci
Affiliations
Iva Gudernova
Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
Silvie Foldynova-Trantirkova
Central European Institute of Technology, Masaryk University, Brno, Czech Republic
Barbora El Ghannamova
Central European Institute of Technology, Masaryk University, Brno, Czech Republic
Bohumil Fafilek
Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic; International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic
Miroslav Varecha
Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic; International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic
Lukas Balek
Department of Experimental Biology, Faculty of Sciences, Masaryk University, Brno, Czech Republic
Eva Hruba
Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic; International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic
Lucie Jonatova
Department of Experimental Biology, Faculty of Sciences, Masaryk University, Brno, Czech Republic
Iva Jelinkova
Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic; International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic
Michaela Kunova Bosakova
Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
Lukas Trantirek
Central European Institute of Technology, Masaryk University, Brno, Czech Republic
Jiri Mayer
Department of Internal Medicine, Hematology and Oncology, Masaryk University Hospital, Brno, Czech Republic
Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic; International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic
In-cell profiling enables the evaluation of receptor tyrosine activity in a complex environment of regulatory networks that affect signal initiation, propagation and feedback. We used FGF-receptor signaling to identify EGR1 as a locus that strongly responds to the activation of a majority of the recognized protein kinase oncogenes, including 30 receptor tyrosine kinases and 154 of their disease-associated mutants. The EGR1 promoter was engineered to enhance trans-activation capacity and optimized for simple screening assays with luciferase or fluorescent reporters. The efficacy of the developed, fully synthetic reporters was demonstrated by the identification of novel targets for two clinically used tyrosine kinase inhibitors, nilotinib and osimertinib. A universal reporter system for in-cell protein kinase profiling will facilitate repurposing of existing anti-cancer drugs and identification of novel inhibitors in high-throughput screening studies.